DR.TODR.TOTSX
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank62
5Y CAGR-38.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
-38.5%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 79.17% |
| Q2 2025 | 41.18% |
| Q1 2025 | -95.16% |
| Q4 2024 | 800.00% |
| Q3 2024 | 2050.00% |
| Q2 2024 | -128.57% |
| Q1 2024 | -84.09% |
| Q4 2023 | 9877.78% |
| Q3 2023 | -103.46% |
| Q2 2023 | -65.79% |
| Q1 2023 | 416.67% |
| Q4 2022 | 36.84% |
| Q3 2022 | -125.68% |
| Q2 2022 | 2127.40% |
| Q1 2022 | -105.37% |
| Q4 2021 | 718.18% |
| Q3 2021 | -164.71% |
| Q2 2021 | 54.55% |
| Q1 2021 | 211.45% |
| Q4 2020 | -198.70% |
| Q3 2020 | 900.00% |
| Q2 2020 | -96.43% |
| Q1 2020 | -56.25% |
| Q4 2019 | 611.11% |
| Q3 2019 | 199.56% |
| Q2 2019 | 72.61% |
| Q1 2019 | -222.22% |
| Q4 2018 | 285.71% |
| Q3 2018 | -65.00% |
| Q2 2018 | 42.86% |
| Q1 2018 | -58.82% |
| Q4 2017 | 409.09% |
| Q3 2017 | -123.91% |
| Q2 2017 | 2871.08% |
| Q1 2017 | -101.82% |
| Q4 2016 | 513.64% |
| Q3 2016 | -22.22% |
| Q2 2016 | 5.26% |
| Q1 2016 | -144.19% |
| Q4 2015 | 258.33% |